Cullinan Therapeutics Investor Relations Material
Latest events
Status Update
Cullinan Therapeutics
Status Update
4 Jun, 2025
Q1 2025
8 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cullinan Therapeutics Inc
Access all reports
Cullinan Oncology Inc, is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Leveraging a modality-agnostic approach, Cullinan Oncology is dedicated to discovering and developing medicines for high-impact oncology targets. The company's strategy involves rigorous and rapid advancement of highly differentiated molecules, resulting in a robust and diversified pipeline of oncology and immuno-oncology therapies. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
CGEM
Country
🇺🇸 United States